A Systematic Review on


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Dec 2021
Historique:
received: 05 11 2021
revised: 05 12 2021
accepted: 11 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 11 1 2022
Statut: epublish

Résumé

Emerging evidence shows that Homeobox (

Identifiants

pubmed: 34948228
pii: ijms222413429
doi: 10.3390/ijms222413429
pmc: PMC8707253
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
HOXB9 protein, human 0
Homeodomain Proteins 0
Neoplasm Proteins 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Mol Med (Berl). 2014 Aug;92(8):811-23
pubmed: 24996520
Int J Cancer. 2006 Oct 15;119(8):1829-36
pubmed: 16721809
Gut. 2017 Jul;66(7):1181-1196
pubmed: 28450390
Nucleic Acids Res. 2016 Dec 15;44(22):10662-10675
pubmed: 27613418
BJU Int. 2014 Apr;113(4):535-40
pubmed: 23937390
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Int J Oncol. 2018 Jun;52(6):2093-2100
pubmed: 29620285
Dig Liver Dis. 2019 Jan;51(1):157-165
pubmed: 30314948
Oncotarget. 2017 May 9;8(19):32322-32331
pubmed: 28423659
Stem Cells Int. 2018 Jul 22;2018:3569493
pubmed: 30154863
Cancers (Basel). 2020 Nov 08;12(11):
pubmed: 33171691
PLoS One. 2010 Apr 29;5(4):e10338
pubmed: 20454457
J Clin Invest. 2010 May;120(5):1535-50
pubmed: 20389018
Oncogene. 2016 Mar 3;35(9):1090-8
pubmed: 26028034
World J Gastroenterol. 2005 Sep 7;11(33):5151-5
pubmed: 16127744
Oncol Rep. 2016 Oct;36(4):1793-8
pubmed: 27499213
Br J Cancer. 2005 Jun 20;92(12):2233-9
pubmed: 15928669
Cancers (Basel). 2019 Apr 12;11(4):
pubmed: 31013831
BMC Cancer. 2020 Sep 9;20(1):866
pubmed: 32907552
RSC Adv. 2013 Jan 1;3(10):3260-3269
pubmed: 23495364
Int J Cancer. 2009 Oct 1;125(7):1532-41
pubmed: 19488988
Clin Cancer Res. 2017 Aug 1;23(15):4312-4322
pubmed: 28298545
Genet Test Mol Biomarkers. 2018 Jun;22(6):390-397
pubmed: 29870276
Oncol Rep. 2010 Mar;23(3):843-51
pubmed: 20127028
Dev Dyn. 2014 Jan;243(1):4-15
pubmed: 23765878
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Lett. 2018 Jul 10;426:63-72
pubmed: 29654889
Biochem Biophys Res Commun. 1997 Mar 27;232(3):742-8
pubmed: 9126347
J Cell Biochem. 2018 Mar;119(3):2864-2874
pubmed: 29073728
Oncogene. 2020 Jan;39(5):1004-1017
pubmed: 31591481
Oncol Res. 2018 Mar 5;26(2):315-322
pubmed: 29137689
Oncotarget. 2016 May 17;7(20):29216-27
pubmed: 27081081
Br J Cancer. 2014 Aug 26;111(5):883-93
pubmed: 25025961
Curr Genomics. 2012 Jun;13(4):300-7
pubmed: 23204919
Tumour Biol. 2020 May;42(5):1010428320918050
pubmed: 32456563
Cancer Hallm. 2013 Sep 1;1(2-3):67-76
pubmed: 24761365
World J Gastroenterol. 2014 Apr 14;20(14):3719-37
pubmed: 24744570
BMC Cancer. 2020 Apr 6;20(1):288
pubmed: 32252672
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1100-5
pubmed: 20080567
Cancer Med. 2020 Jun;9(11):3932-3943
pubmed: 32281284
Life Sci. 2020 Feb 15;243:117230
pubmed: 31923422
J Transl Med. 2018 Dec 12;16(1):350
pubmed: 30541551
Differentiation. 2003 Oct;71(8):461-76
pubmed: 14641327
Chin J Cancer Res. 2014 Feb;26(1):72-80
pubmed: 24653628
Int J Biochem Cell Biol. 2017 Jul;88:1-13
pubmed: 28457970
Oncol Lett. 2016 Nov;12(5):4041-4047
pubmed: 27895768
Oncol Lett. 2018 Mar;15(3):2756-2762
pubmed: 29435001
Dig Dis Sci. 2016 Sep;61(9):2535-44
pubmed: 27165435
World J Hepatol. 2019 Feb 27;11(2):150-172
pubmed: 30820266
J Cell Physiol. 2018 Feb;233(2):727-735
pubmed: 28464221
Cell Adh Migr. 2012 Nov-Dec;6(6):457-70
pubmed: 23076135
Mol Cancer. 2014 May 05;13:102
pubmed: 24885802
Cell Signal. 2020 Feb;66:109469
pubmed: 31733300
Clin Cancer Res. 2011 Jun 1;17(11):3569-78
pubmed: 21474578
Mol Genet Metab. 2014 Jan;111(1):4-15
pubmed: 24239177
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
Br J Cancer. 2021 Feb;124(4):805-816
pubmed: 33214683
Oncol Lett. 2016 Jul;12(1):488-494
pubmed: 27347170
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Int Med Res. 2020 Mar;48(3):300060519883731
pubmed: 31852342
Am J Cancer Res. 2017 Feb 01;7(2):218-233
pubmed: 28337372
J Evid Based Med. 2015 Feb;8(1):2-10
pubmed: 25594108

Auteurs

Eirini Martinou (E)

Hepatobiliary and Pancreatic Surgery Department, Royal Surrey County Hospital, Guildford GU2 7XX, UK.
Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Giulia Falgari (G)

Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Izhar Bagwan (I)

Department of Histopathology and Molecular Biology, Royal Surrey County Hospital, Guildford GU2 7XX, UK.

Angeliki M Angelidi (AM)

Department of Medicine, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA 02215, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH